logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jae-Yong Kwak

Jeonbuk National University
H指数:25
被引数:2,243

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

套细胞淋巴瘤巩固治疗的治疗演变及对生存的影响：来自亚太地区真实世界登记研究的见解

Blood Cancer Journal
IF11.6
2026-05-290
OAAI
Hyungwoo Cho; Koji Kato; Jason Yongsheng Chan; Kim Dajung; Haiwen Huang; Qingqing Cai; Tongyu Lin; Udomsak Bunworasate; Sen-Mui Tan; Ka-Won Kang; Jae-Yong Kwak; Tsai-Yun Chen; Jeong-Ok Lee; Seong Hyun Jeong; Young Rok Do; Esther Chan; Hye Jin Kang; Hyeon-Seok Eom; Sung Yong Oh; Youngil Koh; Hyo Jung Kim; Se-Hyung Kim; Jong Ho Won; Young Hoon Park; Deok Hwan Yang; Soo Chin Ng; Jae-Cheol Jo; Hilman Tadjoedin; Anna Mira Lubis; Noorwati Sutandyo; Tsuyoshi Muta; Ken Takase; Dok Hyun Yoon; Won Seog Kim
A Phase II Clinical Study for Evaluating the Efficacy and Safety of Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone in Transplantation-Eligible Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM2101)

一项评估达拉木单抗、来那度胺、硼替佐米和地塞米松在移植适用老年新诊断多发性骨髓瘤患者中有效性与安全性的II期临床研究（KMM2101）

BLOOD
IF23.1
2024-11-050
PRE
Yoon, Sang Eun; Jung, Sung-Hoon; Lee, Gyeong Won; Min, Chang-Ki; Byun, Ja Min; Kwak, Jae-Yong; Lee, Myung-Won; Lee, Ho Sup; Kim, Seok Jin; Kim, Kihyun
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial

阿卡拉布替尼联合来那度胺和利妥昔单抗治疗复发/难治性侵袭性b细胞非霍奇金淋巴瘤的单臂II期临床试验

NATURE COMMUNICATIONS
IF15.7
2024-03-303
OAAI
Park, Changhee; Lee, Ho Sup; Kang, Ka-Won; Lee, Won-Sik; Do, Young Rok; Kwak, Jae-Yong; Shin, Ho-Jin; Kim, Sung-Yong; Yi, Jun Ho; Lim, Sung-Nam; Lee, Jeong-Ok; Yang, Deok-Hwan; Jang, Hun; Choi, Byoungsan; Lim, Jiwoo; Sun, Choong Hyun; Byun, Ja Min; Yoon, Sung-Soo; Koh, Youngil
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
AMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
2023-01-130
PRE
Kim, Do Young; Kim, Yu Ri; Suh, Cheolwon; Yoon, Dok Hyun; Yang, Deok-Hwan; Park, Yong; Eom, Hyeon Seok; Lee, Jeong-Ok; Kwak, Jae-Yong; Kang, Hye Jin; Hyun, Shin Young; Jo, Jae-Cheol; Chang, Myung Hee; Yoo, Kwai Han; Lim, Sung-Nam; Shin, Ho-Jin; Kim, Won Seog; Kim, In-Ho; Kim, Min Kyung; Kim, Hyo Jung; Lee, Won-Sik; Mun, Yeung-Chul; Kim, Jin Seok
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study
HAEMATOLOGICA
IF7.9
2016-02-17133
OAAI
Lee, Sung-Eun; Choi, Soo Young; Song, Hye-Young; Kim, Soo-Hyun; Choi, Mi-Yeon; Park, Joon Seong; Kim, Hyeoung-Joon; Kim, Sung-Hyun; Zang, Dae Young; Oh, Sukjoong; Kim, Hawk; Do, Young Rok; Kwak, Jae-Yong; Kim, Jeong-A; Kim, Dae-Young; Mun, Yeung-Chul; Lee, Won Sik; Chang, Myung Hee; Park, Jinny; Kwon, Ji Hyun; Kim, Dong-Wook
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2013-03-2853
OA
Lee, Sung-Eun; Choi, Soo Young; Bang, Ju-Hee; Kim, Soo-Hyun; Jang, Eun-jung; Byeun, Ji-Young; Park, Jin-Eok; Jeon, Hye-Rim; Oh, Yun Jeong; Kim, Hyeoung-Joon; Kim, Yeo-Kyeoung; Park, Joon Seong; Jeong, Seong Hyun; Kim, Sung-Hyun; Zang, Dae Young; Oh, Sukjoong; Koo, Dong Hoe; Kim, Hawk; Do, Young Rok; Kwak, Jae-Yong; Kim, Jeong-A; Kim, Dae-Young; Mun, Yeung-Chul; Mauro, Michael J.; Kim, Dong-Wook

研究方向

暂未获取到该数据
C
Chang‐Yeol Yim
H 指数:20论文数:166被引数:1,435
H
Ho‐Young Yhim
H 指数:24论文数:204被引数:1,999
M
Myung‐Hee Sohn
H 指数:30论文数:235被引数:3,294
C
Chul Won Choi
H 指数:34论文数:335被引数:4,401
Y
Yeung‐Chul Mun
H 指数:32论文数:348被引数:3,812
E
Eun‐Kee Song
H 指数:27论文数:129被引数:2,243
C
Cheolwon Suh
H 指数:50论文数:615被引数:1.3万
N
Na‐Ri Lee
H 指数:23论文数:141被引数:1,522
H
Hye Jin Kang
H 指数:32论文数:206被引数:2,921
D
Deok‐Hwan Yang
H 指数:26论文数:247被引数:2,082